Skip to content 
AMM 268: Merz Aesthetics: Transforming Medical Aesthetics into Empowered Self-Care
November 18, 2024
This episode explores Allergan Aesthetics’ recent FDA approval of BOTOX® Cosmetic for reducing the appearance of platysma bands, a first in aesthetic treatments. Dr. Terrence Keaney discusses how this development enhances the range of cosmetic options and impacts overall appearance. Listeners will learn about the clinical trial results, which showed significant patient satisfaction, and how Allergan’s Allē loyalty program supports personalized aesthetic journeys. The episode emphasizes the importance of consulting with licensed specialists to tailor treatments to individual needs.
Quick Takes
- Allergan Aesthetics achieved a milestone with the FDA’s approval of BOTOX® Cosmetic for improving the appearance of platysma bands.
- BOTOX® Cosmetic was previously known for treating forehead lines, frown lines, and crow’s feet, but now it tackles vertical bands that connect the jaw and neck caused by the platysma muscle.
- Clinical trials showed promising results in treating necklines with BOTOX®, with over 60% of patients expressing satisfaction compared to just 12% in those given a placebo.
Episode Transcript
Today, on November 18th, we’re diving into an exciting development in the world of aesthetic medicine. Allergan Aesthetics, an AbbVie company, has achieved a milestone with the FDA’s approval of BOTOX® Cosmetic for a unique use: temporarily improving the appearance of platysma bands. If you’re wondering why this is a big deal, think about it like adding a new string to a musician’s instrument, expanding the range of possibilities.
Until now, BOTOX® Cosmetic was known for treating forehead lines, frown lines, and crow’s feet. With this new approval, it’s the first of its kind to tackle vertical bands that connect the jaw and neck. These bands, formed by the thin platysma muscle, often mar the elegant definition of the jawline. Imagine a sculptor refining a marble bust; BOTOX® smooths out these lines, creating a refined aesthetic.
Dr. Terrence Keaney, a board-certified dermatologist involved in the clinical trials, shares that changes in the neck and lower face can dramatically impact one’s appearance, sometimes unexpectedly. The clinical trials showed promising results, with over 60% of patients expressing satisfaction with their treated necklines compared to just 12% in those given a placebo.
For anyone curious about exploring this treatment, Allergan Aesthetics encourages joining their Allē loyalty program, which rewards patients and simplifies aesthetic choices. This reflects a broader vision not just to enhance surfaces but to empower personal aesthetic journeys.
This approval not only marks a significant innovation in the BOTOX® lineup but also opens up new conversations between patients and their aesthetic specialists. Whether you’re considering this or just curious, always consult a licensed specialist to discuss your aesthetic goals and ensure the treatment fits your needs.
For more in-depth information, visit botoxcosmetic.com, and keep exploring the possibilities that this approval brings!
